Good MorningThe FOMC held its June policy meeting this week and gave the market exactly what it wanted. The Fed says it will continue to support the economy via bond purchases and zero or near-zero interest rates through 2022.
The caveat is that near-term prospects are still dire. The economy is expected to contract sharply in the first half but just how sharply is yet to be seen. The Atlanta Fed’s GDPNow tool is tracking near the -50% mark for the 2nd quarter and the FOMC sees full-year 2020 coming in near -6.5%.
What investors need to focus on is the FOMC's outlook for rebound. Although there is going to be a sharp, severe contraction in GDP in the 2 nd quarter the rebound is already underway. The U.S. economy should see sequential quarterly growth resume as soon as the 3 rd quarter and accelerate over the next two to three. Featured: America's #1 Stock Picker Reveals Next 1,000% Winner (free) (IPM) 
|
Markets | | | This Melt-Up Has Legs
The stock market, despite a widespread and possibly worsening global recession, has been chugging steadily higher for weeks. If you are still wondering why it is because the market is melting up.
In its classic sense, a stock market melt-up is when the market is faced with a ... Read the Full Story |
|
From Our PartnersMarketBeat All Access is our premier research platform that includes MarketBeat Daily Premium, portfolio monitoring tools (My MarketBeat), MarketBeat's full suite of research tools and stock screeners, a real-time news feed, email and SMS alerts, the MarketBeat Idea Engine, proprietary brokerage rankings, extended data export tools and much more. You will also get access to our full database of more than 1 million analyst recommendations, our proprietary broker performance and accuracy ratings and other exclusive benefits.
Through tomorrow night, if you click the link below you will get MarketBeat's flagship subscription, All Access for just $1.00 for your first 30-days. If you want to continue your subscription after that, you'll get a 50% discount on your first year ($19.97 per month instead of $39.97 per month).
| | Start Your 30-Day Risk-Free Trial Subscription Here |
|
Markets | | |
When it comes to finding companies to invest in that provide essential goods and services, you can’t go wrong with consumer staples. These companies produce the kinds of products that people buy on a consistent basis regardless of what the economy is doing. Since the demand for their product... Read the Full Story |
|
Markets | | | Restaurant gaming operator Dave and Busters (NASDAQ: PLAY) shares have quadrupled since its pandemic lows of $4.61 in March 2020. With all 137 locations shut down from the stay-in-shelter mandates since Mar. 20th, revenues have been frozen heading into the Q1 2020 earnings release. Due out Jun. 11, ... Read the Full Story |
|
|
Markets | | | Shares of data analytics platform Cloudera (NASDAQ: CLDR) got pummeled after reporting a (not so) surprising Q1 Fiscal Year 2021 earnings beat on June 3rd. The sell-the-news reaction underscores the recent market earnings reaction template. Stocks that rise sharply heading into an earnings release u... Read the Full Story |
|
Markets | | | Scotts Miracle-Gro Rises After Guidance Update
It was just two weeks ago that analysts at Raymond James gave Scots Miracle-Gro (SMG) a double-downgrade from Strong Buy to Market Perform. According to them, the bull-case inspired by the pandemic was largely played out and the valuation was high. Ana... Read the Full Story |
|
|
The Early Bird Stock Of The Day Arcadia Biosciences, Inc. produces and markets plant-based food and beverage products in the United States. The company develops crop improvements primarily in wheat to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients. Its food, beverage, and body case products include GoodWheat, Zola coconut water, ProVault topical pain relief, and SoulSpring. The company was incorporated in 2002 and is headquartered in Dallas, Texas. | | View Today's Stock Pick |
|
